Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
about
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Study of FAK (Defactinib) and ...... d Solid Malignancies (FAK-PD1)
@en
Study of FAK
@nl
type
label
Study of FAK (Defactinib) and ...... d Solid Malignancies (FAK-PD1)
@en
Study of FAK
@nl
prefLabel
Study of FAK (Defactinib) and ...... d Solid Malignancies (FAK-PD1)
@en
Study of FAK
@nl
P1050
P3098
NCT02758587